bioRxiv Science⌕ Search

bioRxiv · 10.64898/2026.09.16.751136

LAYERED GENOMIC COMPOSITION AND LINGUISTIC CONTINUITY IN GRECIA SALENTINA

Abstract

Grecia Salentina (GS) is the label assigned to a geographic area in Southern Italy where a Greek dialect has historically been spoken. The origins of this Greek-speaking community, whether dating from ancient or Medieval settlement, are a controversial and essentially unsolved issue. To evaluate which historical-linguistic scenario is best supported on genomic grounds, we used whole genome sequencing of 27 GS natives and 21 controls, embedding them in a 799 modern samples dataset in which Greece and Anatolia were evenly represented, an uncommon feature in the genomic literature on the area. We considered different aspects of the genetic structuring, at different spatial and temporal scales. Analyses also included 4021 ancient samples from the literature. All analyses pointed to the same conclusion: the GS genomic profile displays the same characteristic features of the rest of Southern Italy, with no definite evidence for a single source population from outside Italy. Correspondingly, we detected strong genetic connectivity among GS municipalities and between GS and the rest of Italy. Only a subset of our analyses suggested a slightly increased affinity of GS with Greece, or with the Anatolian peninsula. These results indicate that GS has been all but a genetically closed community, and that the Greek language did not act as a barrier to gene flow. By endorsing a ''transient mobility model'' we support the most recent linguistic hypothesis: the prolonged resilience of the Greek language in GS, maintained in situ and periodically rejuvenated through recurrent external inputs from the Greek and Byzantine worlds.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Cangialosi, G., Guli, M., Menato, F., Pepe, G., Mercuri, E., Zangaro, F., Jodice, C., Cruciani, F., Trombetta, B., Helmer-Citterich, M., Akar, N., Guardiano, C., Longobardi, G., Specchia, V., Semino, O., D'Atanasio, E., Novelletto, A.. 2026-09-17. LAYERED GENOMIC COMPOSITION AND LINGUISTIC CONTINUITY IN GRECIA SALENTINA. https://doi.org/10.64898/2026.09.16.751136

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

OPA1 controls mitochondrial dysfunction-driven liver fibrosis in MASLD

Progressive hepatic fibrosis is the principal determinant of morbidity and mortality in metabolic dysfunction-associated steatotic liver disease and steatohepatitis (MASLD/MASH). Mitochondrial dysfunction is a hallmark of MASH, and the release of mitochondrial damage-associated molecular patterns (mito-DAMPs) from injured hepatocytes can promote fibrosis. However, how mitochondrial dynamics and quality control shape the fibrotic response in MASLD/MASH remains unclear. Here, through large-scale genomic analyses of mitochondrial genes governing mitophagy, fusion and fission in human MASLD, with a power-equivalent sample size of approximately 700,000 individuals, we identify a strong association between hepatic fibrosis and the mitochondrial fusion factor dynamin-like GTPase optic atrophy 1 (OPA1). OPA1 transcripts and protein abundance in the liver epithelium were progressively dysregulated with advancing fibrosis. In mice, hepatocyte-specific OPA1 loss alone was sufficient to induce hepatic stellate cell activation and fibrosis in zone 3, promoted the release of mito-DAMPs into the circulation and exacerbated fibrosis in experimental MASH. These findings identify OPA1 as a central regulator of the hepatic fibrotic response and connect defective mitochondrial homeostasis to mito-DAMP release, hepatic stellate cell activation and fibrosis in MASLD.

genetics↗

Temporal control of mitochondrial mutagenesis reveals the fate of mtDNA mutations with age

Mutations in the mitochondrial genome (mtDNA) play a critical role in the aging process and a wide variety of age-related diseases. However, it remains unclear when the mutations that drive physiological decline arise. To answer this question, we generated a new mouse model in which mitochondrial mutagenesis can be confined to a defined window of time. Surprisingly, we found that mutations that arise during the first two months of life are sufficient to drive a wide variety of age-related pathologies, and that the severity of this pathology is broadly regulated by distinct, tissue-specific selective pressures that control the fate of mtDNA mutations with age. Further, we found that selection against deleterious variants can be modulated by manipulation of mitochondrial fusion in vitro and in vivo. These observations raise the possibility that in some tissues, the pace of aging is pre-determined by events that occur early in life and that interventions targeting mitochondrial fusion may be able to slow down or reverse the expansion of these pathogenic variants. These results carry far-reaching implications for strategies aimed at preventing or delaying age-related decline.

genetics↗

Innate immune stress pathway activation underlies heterochromatin dysfunction pathology

Heterochromatin loss disrupts nuclear architecture, gene regulation and repetitive element silencing, and is associated with diverse human diseases. However, mechanisms linking heterochromatin dysfunction to pathological phenotypes remain unclear. Using genetic interaction screening and genomic analyses in C. elegans, we identify secondary activation of the Intracellular Pathogen Response (IPR), an innate immune stress pathway, as a major contributor to heterochromatin mutant phenotypes. Constitutive IPR activation phenocopies slow growth and indirect transcriptional changes observed in these mutants. Depletion of genetic enhancers further increased, whereas suppressor RNAi attenuated IPR activation, with direct heterochromatin targets remaining substantially deregulated. Notably, many suppressors encode active chromatin components, and mild reduction of RNA polymerase II activity ameliorates growth defects in C. elegans HP1 mutants and human HP1-deficient cells. Our findings reveal secondary stress response activation as an important mechanism linking heterochromatin dysfunction to pathology and identify transcriptional dampening as a potential therapeutic strategy for mitigating these effects.

genetics↗